These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 2711405)
1. Interspecies comparison of pharmacokinetic profile and bioavailability of (+/-)-gossypol in male Fischer-344 rats and male B6C3F mice. Abou-Donia MB; Othman MA; Obih P Toxicology; 1989 Apr; 55(1-2):37-51. PubMed ID: 2711405 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic profile of (+/-)-gossypol in male Sprague-Dawley rats following single intravenous and oral and subchronic oral administration. Othman MA; Abou-Donia MB Proc Soc Exp Biol Med; 1988 May; 188(1):17-22. PubMed ID: 3368474 [TBL] [Abstract][Full Text] [Related]
3. Comparison of pharmacokinetic and metabolic profiling among gossypol, apogossypol and apogossypol hexaacetate. Jia L; Coward LC; Kerstner-Wood CD; Cork RL; Gorman GS; Noker PE; Kitada S; Pellecchia M; Reed JC Cancer Chemother Pharmacol; 2008 Jan; 61(1):63-73. PubMed ID: 17356822 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics, tissue distribution, and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD2F1 mice and Fischer 344 rats. Egorin MJ; Lagattuta TF; Hamburger DR; Covey JM; White KD; Musser SM; Eiseman JL Cancer Chemother Pharmacol; 2002 Jan; 49(1):7-19. PubMed ID: 11855755 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of (+/-)-, (+)-, and (-)-gossypol in humans and dogs. Wu DF; Yu YW; Tang ZM; Wang MZ Clin Pharmacol Ther; 1986 Jun; 39(6):613-8. PubMed ID: 3709025 [TBL] [Abstract][Full Text] [Related]
6. Plasma pharmacokinetics and bioavailability of 1-(2-chloroethyl)-3-sarcosinamide-1-nitrosourea after intravenous and oral administration to mice and dogs. Supko JG; Garcia-Carbonero R; Puchalski TA; Malspeis L Cancer Chemother Pharmacol; 2001 Sep; 48(3):202-8. PubMed ID: 11592341 [TBL] [Abstract][Full Text] [Related]
7. Comparative study on the metabolism of optical gossypol in rats. Chen QQ; Chen H; Lei HP J Ethnopharmacol; 1987 Jun; 20(1):31-7. PubMed ID: 3626594 [TBL] [Abstract][Full Text] [Related]
8. The effects of dose, route, and repeated dosing on the disposition and kinetics of tetrabromobisphenol A in male F-344 rats. Kuester RK; Sólyom AM; Rodriguez VP; Sipes IG Toxicol Sci; 2007 Apr; 96(2):237-45. PubMed ID: 17234645 [TBL] [Abstract][Full Text] [Related]
9. Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouse. Sauer JM; Bao J; Smith RL; McClure TD; Mayersohn M; Pillai U; Cunningham ML; Sipes IG Drug Metab Dispos; 1997 Mar; 25(3):371-8. PubMed ID: 9172957 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and tissue distribution of halofuginone (NSC 713205) in CD2F1 mice and Fischer 344 rats. Stecklair KP; Hamburger DR; Egorin MJ; Parise RA; Covey JM; Eiseman JL Cancer Chemother Pharmacol; 2001 Nov; 48(5):375-82. PubMed ID: 11761455 [TBL] [Abstract][Full Text] [Related]
11. The pharmacokinetics and oral bioavailability studies of columbianetin in rats after oral and intravenous administration. Luo Q; Wang CP; Li J; Ma WF; Bai Y; Ma L; Gao XM; Zhang BL; Chang YX J Ethnopharmacol; 2013 Oct; 150(1):175-80. PubMed ID: 23994338 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and tissue and tumor exposure of CP-31398, a p53-stabilizing agent, in rats. Kapetanovic IM; Muzzio M; McCormick DL; Thompson TN; Johnson WD; Horn TL; Mohammed A; Rao CV; Kopelovich L Cancer Chemother Pharmacol; 2012 May; 69(5):1301-6. PubMed ID: 22302406 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic properties of ethosuximide in monkeys. I. Single-dose intravenous and oral administration. Patel IH; Levy RH; Bauer TG Epilepsia; 1975 Dec; 16(5):705-16. PubMed ID: 816644 [TBL] [Abstract][Full Text] [Related]
15. Interspecies pharmacokinetic scaling of oltipraz in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics. Bae SK; Lee SJ; Kim YG; Kim SH; Kim JW; Kim T; Lee MG Biopharm Drug Dispos; 2005 Apr; 26(3):99-115. PubMed ID: 15723427 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of pipemidic acid in chickens after single intravenous and oral dosings. Anadón A; Martínez-Larrañaga MR; Díaz MJ; Vélez C; Bringas P Am J Vet Res; 1990 Nov; 51(11):1756-9. PubMed ID: 2240801 [TBL] [Abstract][Full Text] [Related]
17. Toxicokinetics of pentachloroanisole in F344 rats and B6C3F1 mice. Yuan JH; Goehl TJ; Murrill E; Moore R; Clark J; Hong L; Irwin R Xenobiotica; 1993 Apr; 23(4):427-38. PubMed ID: 8337901 [TBL] [Abstract][Full Text] [Related]
18. Bioavailability and pharmacokinetic studies of eurycomanone from Eurycoma longifolia. Low BS; Ng BH; Choy WP; Yuen KH; Chan KL Planta Med; 2005 Sep; 71(9):803-7. PubMed ID: 16206032 [TBL] [Abstract][Full Text] [Related]
19. Preclinical pharmacology of the novel antitumor agent adaphostin, a tyrphostin analog that inhibits bcr/abl. Li M; Wang H; Hill DL; Stinson S; Veley K; Grossi I; Peggins J; Covey JM; Zhang R Cancer Chemother Pharmacol; 2006 May; 57(5):607-14. PubMed ID: 16331493 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and systemic bioavailability of menogaril, an anthracycline antitumor agent, in the mouse, dog, and monkey. Adams WJ; McGovren JP; Dalm EA; Brewer JE; Hosley JD Cancer Res; 1989 Nov; 49(22):6328-36. PubMed ID: 2529962 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]